Atherosclerosis

There are 1,999 papers on atherosclerosis in aging research: 59 trials and 559 observational studies in people, 373 in animals, 45 in cells, 922 reviews. The newest story, Nov 16, 2026: “Loss of nuclear support proteins harms mouse hearts and arteries”.

Disease

1,999 papers study it2,674 more mention it576 findings

MeSH

397 new papers in 30 daysSee all 4,674 papers on atherosclerosis

At a glance

Human studies link atherosclerosis with increasing frailty in people with type 2 diabetes and sarcopenia in older patients. A human preprint links carotid plaques without stenosis with higher dementia risk. Mouse studies report reductions with exercise and quercetin, but caloric restriction decreases atherosclerosis in obese hypercholesterolemic mice and increases it in ApoE-deficient mice fed chow or HCHF diets.

576 findings in 482 papers from 1996 to 2026, 88 of them since April 2026

“after FGR the increased risk of atherosclerosis was most notable.”
Cardiovascular Disease in Women the Two Decades Following Uteroplacental Disorders: A Population‐Based Data‐Linkage StudyBJOG : an international journal of obstetrics and gynaecology2026doi:10.1111/1471-0528.70363
  • Human trial59
  • Humans559
  • Animals373
  • Cells45
  • In silico26

Interventions

128

Caloric restriction

downin mice4upin mice2no changein mice1

7 studies
  1. Caloric restriction increases atherosclerosis in ApoE-deficient mice fed Chow or HCHF diet.

    “MfR improved insulin sensitivity by lowering blood glucose and triglycerides but increased circulating cholesterol and accelerated atherosclerosis.”

    Animalsin ApoE-deficient mice fed Chow or HCHF dietsix months

    Mild caloric restriction accelerates atherosclerosis in mice

    JCI insight

  2. Caloric restriction decreases atherosclerosis in obese hypercholesterolemic mice.

    “Weight loss promoted atherosclerosis resolution independent of plasma cholesterol.”

    Animalsin obese hypercholesterolemic mice

    Caloric restriction promotes resolution of atherosclerosis in obese mice, while weight regain accelerates its progression

    The Journal of clinical investigation

  3. Caloric restriction induces atherosclerosis in mice (ApoE/LDLr-/-).

    “CR induced atherosclerosis in young mice.”

    AnimalsApoE/LDLr-/-8 weeksmales

    Negative Impact of Caloric Restriction on Atherosclerosis in Young ApoE/LDLr -/- Mice

    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

  4. Caloric restriction decreases atherosclerosis in obese hypercholesterolemic mice.

    “Weight loss was found to promote atherosclerosis resolution independent of plasma cholesterol.”

    Animalsin obese hypercholesterolemic mice

    SHORT-TERM CALORIC RESTRICTION IN MICE PROMOTES RESOLUTION OF ATHEROSCLEROSIS, WHILE WEIGHT REGAIN ACCELERATES ITS PROGRESSION

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  5. Caloric restriction decreases atherosclerosis in mice (apoE-deficient mice compared with high-fat diet).

    “compared with HFD, CRD substantially reduced atherosclerosis in mice”

    AnimalsapoE-deficient mice compared with high-fat diet2% fat plus 0.5% cholesterol dietatherosclerotic lesion~40% calorie restriction16 weeks

    Food with calorie restriction reduces the development of atherosclerosis in apoE-deficient mice

    Biochemical and biophysical research communications

  6. Caloric restriction showed no clear effect on atherosclerosis in mice (weight-matched to 10,12 CLA-treated mice).

    “only the 10,12 CLA-treated mice had improved en face and aortic sinus atherosclerosis”

    Animalsweight-matched to 10,12 CLA-treated mice8 weeksmales

    10,12 Conjugated Linoleic Acid-Driven Weight Loss Is Protective against Atherosclerosis in Mice and Is Associated with Alternative Macrophage Enrichment in Perivascular Adipose Tissue

    Nutrients

  7. Caloric restriction decreases atherosclerosis in obese diabetic double knock-out mice.

    “Caloric restriction increased mitochondria-encoded cytochrome oxidase 1 and reduced plaque area and oxidized LDL.”

    Animalsin obese diabetic double knock-out miceaortic arch

    Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs

    PloS one

More on Caloric restriction

Resveratrol

downin reviews3downin mice2

5 studies
  1. Resveratrol decreases atherosclerosis in mice (AAV-mediated GATA4 overexpression, high-fat diet).

    “These effects were counteracted by either AAV-Sortilin shRNA or dietary Res supplementation”

    AnimalsAAV-mediated GATA4 overexpression, high-fat dietaorta

    Resveratrol suppresses GATA4/Sortilin pathway to attenuate vascular smooth muscle cell senescence-associated secretory phenotype and vascular aging-related atherosclerosis

    Cellular signalling

  2. Resveratrol decreases atherosclerosis.

    “Resveratrol inhibiting TGF/ERK signaling pathway can improve atherosclerosis”

    Review

    Resveratrol inhibiting TGF/ERK signaling pathway can improve atherosclerosis: backgrounds, mechanisms and effects

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  3. Resveratrol protects against atherosclerosis.

    “cardiovascular protective capacities of resveratrol are associated with multiple molecular targets and may lead to the development of novel therapeutic strategies for atherosclerosis”

    Review

    A comprehensive review of the health perspectives of resveratrol

    Food & function

  4. Resveratrol decreases atherosclerosis in animal models.

    “Resveratrol reduces the extent of atherosclerosis in animal model of atherosclerosis”

    Reviewin animal models

    Resveratrol, wine, and atherosclerosis

    The International journal of angiology : official publication of the International College of Angiology, Inc

  5. Resveratrol protects against atherosclerosis.

    “This evidence identified RS as an effective anti-atherogenic agent, which could be used in the prevention and treatment of CVD.”

    Review

    Anti-atherogenic effects of resveratrol

    European journal of clinical nutrition

More on Resveratrol

Quercetin

downin mice3downin reviews2

5 studies
  1. Quercetin protects against atherosclerosis in atherosclerosis.

    “highlights the potential of TCM monomers to stabilize plaques”

    Reviewin atherosclerosis

    Phytochemical Monomers Derived from Traditional Chinese Medicine May Prevent and Treat Atherosclerosis by Modulating the Macrophage Mitochondrial-Lysosomal Senescence Axis

    International journal of general medicine

  2. Quercetin protects against atherosclerosis in mice.

    “subchronic exposure to PM2.5 and O3 contributes to cardiac injury and accelerates the progression of atherosclerosis in mice and this detrimental effect can be mitigated by the administration of quercetin.”

    Animalsin mice

    Quercetin mitigates cardiovascular injury induced by subchronic exposure to PM2.5 and O₃ via modulation of lipid metabolism and MAPK signaling

    Ecotoxicology and environmental safety

  3. Quercetin decreases atherosclerosis in ovariectomized ApoE-/- mice on a high-fat diet.

    “Both QCT and Fer-1 significantly attenuated postmenopausal atherosclerosis progression”

    Animalsin ovariectomized ApoE-/- mice on a high-fat dietfemales

    Quercetin alleviates postmenopausal atherosclerosis by suppressing endothelial cell ferroptosis via regulating the KEAP1/NRF2/GPX4 signalling pathway

    British journal of pharmacology

  4. Quercetin decreases atherosclerosis in high-fat diet-fed ApoE-/- mice.

    “quercetin supplementation effectively reduced the amount of senescent plaque macrophage, inhibited the secretion of key senescence-associated secretory phenotype factors, and alleviated atherosclerosis”

    Animalsin high-fat diet-fed ApoE-/- mice100 mg/kg of body weight16 weeks

    Quercetin alleviates atherosclerosis by suppressing oxidized LDL-induced senescence in plaque macrophage via inhibiting the p38MAPK/p16 pathway

    The Journal of nutritional biochemistry

  5. Quercetin protects against atherosclerosis.

    “This review discusses the possible antiatherogenic role of 3 flavonoids, namely, chrysin, quercetin, and luteolin primarily known for their antiinflammatory properties.”

    Review

    Antiatherogenic Roles of Dietary Flavonoids Chrysin, Quercetin, and Luteolin

    Journal of cardiovascular pharmacology

More on Quercetin

Dehydroepiandrosterone

downin humans2no changein humans1downin reviews1

4 studies
  1. Dehydroepiandrosterone prevents atherosclerosis in humans (middle-aged people).

    “DHEA has beneficial effects on the prevention of atherosclerosis based on visceral obesity-induced metabolic syndrome in middle-aged people.”

    Reviewmiddle-aged people

    Anti-aging effects of the adrenal androgens dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanisms of action and beneficial effects in older people

    Endocrine journal

  2. Dehydroepiandrosterone inhibits atherosclerosis in postmenopausal women.

    “DHEA inhibits AS, thus inhibiting the development of CVD, and it improves the prognosis for CVD.”

    Reviewin postmenopausal women

    Effect of dehydroepiandrosterone on atherosclerosis in postmenopausal women

    Bioscience trends

  3. Dehydroepiandrosterone showed no clear effect on atherosclerosis in humans.

    “interventional trials show no improvement in atherosclerosis or cardiovascular risk factors”

    Revieworalfemales

    Dehydroepiandrosterone sulfate and postmenopausal women

    Current opinion in endocrinology, diabetes, and obesity

  4. Dehydroepiandrosterone inhibits atherosclerosis.

    “DHEA and related steroids inhibit inflammation and associated epithelial hyperplasia, carcinogenesis, and atherosclerosis”

    Review

    Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity

    Ageing research reviews

More on Dehydroepiandrosterone

Estradiol

downin mice2upin mice1

3 studies
  1. Estradiol decreases atherosclerosis in mice (young mice).

    “In contrast to aging mice, young mice exhibited reduced systemic and plaque inflammation, improved HDL functions and atherosclerosis following E2 treatment.”

    Animalsyoung micefemales

    Cardiovascular Benefits of Menopause Hormone Treatment is Age-Dependent

    bioRxiv : the preprint server for biologyPreprint

  2. Estradiol increases atherosclerosis in mice (combined with estradiol and iron).

    “cellular cholesterol efflux was reduced and endothelial homeostasis was disrupted and, consequently, atherosclerosis was aggravated.”

    Animalscombined with estradiol and iron

    Aging-related iron deposit prevents the benefits of HRT from late postmenopausal atherosclerosis

    Preprint

  3. Estradiol decreases atherosclerosis in ovariectomized ApoE-knockout mice.

    “Administration of 17β-estradiol (E2) for eight weeks to OVX mice restored aortic SIRT1 expression, activated eNOS, and retarded OVX-induced arterial senescence and atherosclerotic development”

    Animalsin ovariectomized ApoE-knockout miceaortaeight weeksfemalesn = 5

    Estrogen-SIRT1 Axis Plays a Pivotal Role in Protecting Arteries Against Menopause-Induced Senescence and Atherosclerosis

    Journal of atherosclerosis and thrombosis

More on Estradiol

Statins

downin humans2downin reviews1

3 studies
  1. Statins decrease atherosclerosis.

    “This reduces atherosclerotic tenor within the blood vessels showing the beneficial effect of statin drugs.”

    Review

    Multiphasic Venture of Cholesterol Homeostasis: A Perspective on Statin Therapy

    Journal of biochemical and molecular toxicology

  2. Statins prevent atherosclerosis in humans.

    “Statins are one of the leading pharmacological interventions against atherosclerosis”

    Review

    Dyslipidemia and Cardiovascular Prevention in the Elderly: A Balance between Benefits and Risks of Statin Treatment in a Specific Population

    Endocrine, metabolic & immune disorders drug targets

  3. Statins decrease atherosclerosis in humans.

    “The discovery of statins was the revolution that made it possible to delay and stop the progression of the atherosclerotic process”

    Review

    From statin revolution to gene silencing therapy: 50 years of evolution in the treatment of hypercholesterolemia

    Giornale italiano di cardiologia (2006)

More on Statins

Fisetin

downin mice2downin reviews1

3 studies
  1. Fisetin protects against atherosclerosis (experimental atherosclerosis).

    “a growing body of evidence has unveiled the anti-atherosclerotic properties of fisetin, a natural polyphenol compound”

    Reviewexperimental atherosclerosis

    The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review

    The Journal of pharmacy and pharmacology

  2. Fisetin decreases atherosclerosis in ApoE-/- mice.

    “the formation of atherosclerosis was also suppressed by fisetin in ApoE-/- mice”

    Animalsin ApoE-/- mice

    Fisetin Suppresses Atherosclerosis by Inhibiting Ferroptosis-Related Oxidative Stress in Apolipoprotein E Knockout Mice

    Pharmacology

  3. Fisetin decreases atherosclerosis in STZ-induced diabetic LDLR-/- mice.

    “We found that fisetin treatment effectively attenuated diabetes-exacerbated atherosclerosis.”

    Animalsin STZ-induced diabetic LDLR-/- mice12 weeks

    Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway

    Acta pharmacologica Sinica

More on Fisetin

Berberine

downin reviews3

3 studies
  1. Berberine decreases atherosclerosis.

    “BBR alleviated atherosclerosis by attenuation of dyslipidemia, correction of endothelial dysfunction, inhibition of macrophage inflammation and foam cell formation”

    Review

    Atheroprotective Effects and Molecular Mechanism of Berberine

    Frontiers in molecular biosciences

  2. Berberine decreases atherosclerosis.

    “attenuates the development of atherosclerosis, and reduces hypertension”

    Review

    Biological properties and clinical applications of berberine

    Frontiers of medicine

  3. Berberine protects against atherosclerosis.

    “The review covers several therapeutic effects of berberine, its derivatives and pharmaceutical formulations against cancer, obesity, diabetes, inflammation, atherosclerosis, Alzheimer's disease, rheumatoid arthritis and cardiovascular diseases.”

    Review

    Pharmacological effects of berberine and its derivatives: a patent update

    Expert opinion on therapeutic patents

More on Berberine

Taurine

downin reviews2downin L. animals1

3 studies
  1. Taurine decreases atherosclerosis in genetic and dietary models of hyperlipidemia.

    “taurine supplementation retards the initiation and progression of atherosclerosis”

    Reviewin genetic and dietary models of hyperlipidemia

    Taurine and atherosclerosis

    Amino acids

  2. Taurine decreases atherosclerosis (experimental work cited in the review).

    “Recent epidemiological surveys revealed the involvement of inflammatory mediators in the pathogenesis of stroke and also atherosclerosis for which T was proven to be effective experimentally.”

    Reviewexperimental work cited in the review

    Taurine in health and diseases: consistent evidence from experimental and epidemiological studies

    Journal of biomedical science

  3. Taurine decreases atherosclerosis.

    “antioxidant, antiatherogenic and blood pressure-lowering effects”

    Review

    The potential health benefits of taurine in cardiovascular disease

    Experimental and clinical cardiology

More on Taurine

Electronegative hdl subfraction H5

upin mice2

2 studies
  1. Electronegative hdl subfraction H5 increases atherosclerosis in mice (mediated by p53-p21 signaling).

    “In mice, H5-induced dysfunction promoted a pro-atherogenic phenotype, mediated centrally by the p53-p21 signaling axis.”

    Animalsmediated by p53-p21 signaling

    Abnormal cholesterol carrier linked to artery plaque in people

    GeroScience

  2. Electronegative hdl subfraction H5 increases atherosclerosis in mice.

    “H5-treated mice exhibited marked lipid-rich aortic plaques and increased collagen deposition, while H1 and saline controls showed minimal pathology”

    Animalsaorta

    In Vivo and Clinical Evidence of HDL Electronegativity in Atherogenicity

    AHA Scientific Sessions 2025 abstract

More on Electronegative hdl subfraction H5

Allogeneic umbilical cord blood cells

downin humans1

1 study
  1. Allogeneic umbilical cord blood cells decrease atherosclerosis in humans (HGPS).

    “One year after therapy initiation, evident amelioration in pulse wave velocity, bilateral maximal intima-media thickness, and dyslipidemic status were observed”

    Human trialHGPSallogeneic cord blood cells from unrelated donorsthree intravenous infusions at four-month intervalsone yearmales

    Efficacy of Cord Blood Cell Therapy for Hutchinson-Gilford Progeria Syndrome-A Case Report

    International journal of molecular sciences

More on Allogeneic umbilical cord blood cells

All 128

Effects

22

Inflammation

no changein humans1upin humans1

2 studies
  1. Atherosclerosis was not clearly linked with inflammation in humans (atherosclerosis).

    “classical inflammatory markers showed no significant differences”

    Humansatherosclerosis

    Integrative multi-omics analysis identifies a robust 14-metabolite signature and reveals microbiome-metabolite-host interactions in atherosclerosis

    Frontiers in cardiovascular medicine

  2. Atherosclerosis induces inflammation in humans.

    “Atherosclerosis causes low-grade inflammation from the endothelial side”

    Review

    Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders

    Frontiers in aging neuroscience

More on Inflammation

Cognitive function

downin humans2−10% variance

2 studies
  1. Atherosclerosis is linked with worse cognitive function in humans (preclinical or at-risk states for AD, Braak stage I or II) (10.4% of variance).

    “Greater neurofibrillary tangle density and atherosclerosis explained 10.4% of the variance in primacy decline.”

    Humanspreclinical or at-risk states for AD, Braak stage I or IIbrainn = 141

    Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies

    Journal of the International Neuropsychological Society : JINS

  2. Atherosclerosis is linked with worse cognitive function in humans (adjusted for sex, education level, TMT B at age 75 and Framingham score at age 70) (P<0·0001).

    “TAS at age 70 was significantly related to the individual change in TMT B (P<0·0001) between age 75 and 80”

    Humansadjusted for sex, education level, TMT B at age 75 and Framingham score at age 705 yearsn = 190

    Total atherosclerotic burden measured by magnetic resonance imaging is related to five-year decline in cognitive function

    Clinical physiology and functional imaging

hematopoietic stem cell proliferation

upin humans1upin mice1

1 study
  1. Atherosclerosis is linked with higher hematopoietic stem cell proliferation in humans.

    “hematopoietic stem cell division rates are increased in mice and humans with atherosclerosis”

    Humans

    Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis

    Cell

  2. Atherosclerosis increases hematopoietic stem cell proliferation in mice.

    “hematopoietic stem cell division rates are increased in mice and humans with atherosclerosis”

    Animals

    Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis

    Cell

CDKN2A

upin humans1

1 study
  1. Atherosclerosis is linked with higher CDKN2A in humans (atherosclerosis).

    “senescence markers P16 and P21 were significantly elevated in AS”

    Humansatherosclerosis

    Integrative multi-omics analysis identifies a robust 14-metabolite signature and reveals microbiome-metabolite-host interactions in atherosclerosis

    Frontiers in cardiovascular medicine

More on CDKN2A

Alpha-klotho expression

downin humans1

1 study
  1. Atherosclerosis is linked with lower alpha-klotho expression in humans.

    “α-Klotho expression was significantly reduced in atherosclerotic vessels and stenotic AVs.”

    Humansaorta, carotid and femoral arteriesn = 112

    Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease

    Biochemical pharmacology

More on Alpha-klotho expression

TRAF3

upin mice1

1 study
  1. Atherosclerosis increases TRAF3 in mice (fed a high-fat diet).

    “In ApoE-/- mice, TRAF3 protein expression was increased in atherosclerotic lesions, predominantly within the tunica intima.”

    Animalsfed a high-fat dietatherosclerotic lesions

    The miR-2110/TRAF3 axis is associated with endothelial dysfunction and atherosclerosis in coronary heart disease

    Biochemistry and biophysics reports

More on TRAF3

Microcirculatory function

downin reviews1

1 study
  1. Atherosclerosis impairs microcirculatory function in aging.

    “atherosclerotic vascular impairment compromises microcirculatory function, inducing muscle ischemia and metabolic decline”

    Reviewin aging

    Unraveling the metabolic pathways between atherosclerosis and sarcopenia

    Frontiers in endocrinology

Age of onset of arteriolosclerosis

downin humans1

1 study
  1. Atherosclerosis is linked with lower age of onset of arteriolosclerosis in humans.

    “Arteriolosclerosis, atherosclerosis, and macroscopic infarcts were associated with earlier onset.”

    Humansn = 1,195

    Understanding Race and Sex Differences in Age of Onset of Arteriolosclerosis with an MRI‐based in‐vivo Classifier

    AAIC 2025 abstract

MMU-miR-23B ~ miR-24-2 ~ miR-27B locus

upin mice1

1 study
  1. Atherosclerosis increases MMU-miR-23B ~ miR-24-2 ~ miR-27B locus in mice (late disease atherosclerosis).

    “Upregulation of the immunosuppressive mmu-mir-23b ~ mir-24-2 ~ mir-27b locus was specific to Trem2 + lipid-associated macrophages, prevalent at late disease.”

    Animalslate disease atherosclerosisadipose tissue

    MicroRNA gene dynamics in immune cell subpopulations during aging and atherosclerosis disease development at single-cell resolution

    Genome medicine

More on MMU-miR-23B ~ miR-24-2 ~ miR-27B locus

MMU-miR-511

upin mice1

1 study
  1. Atherosclerosis increases MMU-miR-511 in mice (atherosclerosis progression).

    “Atherosclerosis progression is reflected within adipose tissue as expansion of the myeloid compartment, with elevated pro-inflammatory mmu-mir-511 expression in several macrophage subtypes.”

    Animalsatherosclerosis progressionadipose tissue

    MicroRNA gene dynamics in immune cell subpopulations during aging and atherosclerosis disease development at single-cell resolution

    Genome medicine

More on MMU-miR-511

All 22

Upstream

86

Cellular senescence

upin humans2upin mice2upin reviews2

6 studies
  1. Cellular senescence increases atherosclerosis (disrupted balance of macrophage migration).

    “We believe that senescence disrupts the balance of macrophage migration, thereby exacerbating atherosclerosis”

    Reviewdisrupted balance of macrophage migration

    The role of macrophages in the relationship between senescence and atherosclerosis

    Biochemistry and biophysics reports

  2. Cellular senescence increases atherosclerosis in humans.

    “Endothelial cell (EC) senescence is a fundamental driver of atherosclerosis.”

    Reviewendothelial cell

    Beyond a gatekeeper: the non-classical signaling role of STRA6 in driving endothelial senescence and atherosclerosis

    Frontiers in immunology

  3. Cellular senescence increases atherosclerosis in mice with VSMC-restricted TRF2T188A expression.

    “Mice expressing a VSMC-restricted mutant telomere protein (TRF2T188A) that induces premature senescence showed increased atherosclerosis”

    Animalsin mice with VSMC-restricted TRF2T188A expressionaorta

    Premature cell senescence promotes vascular smooth muscle cell phenotypic modulation and resistance to re-differentiation

    Cardiovascular research

  4. Cellular senescence increases atherosclerosis in mice (endothelial cell-specific dominant negative TRF2 overexpression in ApoE-deficient mice).

    “EC-specific progeria accelerated atherosclerosis in mice with target deletion of ApoE.”

    Animalsendothelial cell-specific dominant negative TRF2 overexpression in ApoE-deficient mice

    Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis

    Scientific reports

  5. Cellular senescence increases atherosclerosis.

    “has been demonstrated to contribute to different stages of atheroma development”

    Review

    Cell Senescence, Multiple Organelle Dysfunction and Atherosclerosis

    Cells

  6. Cellular senescence increases atherosclerosis in humans.

    “an increasing body of evidence shows that cell senescence plays an indispensable role in the formation and development of atherosclerosis”

    Review

    The emerging role of cell senescence in atherosclerosis

    Clinical chemistry and laboratory medicine

More on Cellular senescence

Inflammation

upin reviews3upin humans2

5 studies
  1. Inflammation increases atherosclerosis.

    “The latter two processes are major promoters of the onset and progression of atherosclerosis.”

    Review

    Cardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review

    Medicina (Kaunas, Lithuania)

  2. Inflammation increases atherosclerosis in humans.

    “These include aberrant cytokine production, inflammasome activation, and other proinflammatory mechanisms, which can accelerate atherosclerosis, promote thrombogenesis, and impair vascular or myocardial function.”

    Review

    Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association

    Circulation

  3. Inflammation increases atherosclerosis in humans (estrogen decline after menopause).

    “chronic inflammation, which in turn promotes atherosclerosis, osteoporosis, and cognitive decline.”

    Reviewestrogen decline after menopausefemales

    The Interplay of Aging and the Immune System

    Missouri medicine

  4. Inflammation increases atherosclerosis.

    “Key inflammatory mediators involved in inflammaging contribute to endothelial dysfunction and accelerate the progression of atherosclerosis.”

    Review

    Mechanisms Underlying Vascular Inflammaging: Current Insights and Potential Treatment Approaches

    Aging and disease

  5. Inflammation increases atherosclerosis.

    “Inflammatory pathways contribute to the initiation, the progression, and the complication of both malignant tumours and atherosclerotic plaques.”

    Review

    Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology

    Cardiovascular research

More on Inflammation

SIRT6

downin mice2downin reviews2

4 studies
  1. SIRT6 protects against atherosclerosis.

    “Sirt6 exhibits anti-atherosclerotic properties by enhancing DNA repair in endothelial cells, reducing lipid accumulation in macrophages, and promoting cholesterol transport via ATP-Binding Cassette A1 (ABCA1).”

    Review

    The multi-dimensional regulatory mechanism of Sirt6 in heart health: From cell death pathways to targeted therapy for cardiovascular diseases

    Biochemical and biophysical research communications

  2. SIRT6 protects against atherosclerosis in mice (hepatocyte SIRT6 manipulation in Ldlr-/- mice on Western diet).

    “In conclusion, our data indicate that hepatocyte SIRT6 protects against atherosclerosis, NAFLD, and obesity by regulating lipid metabolism in the liver and intestine.”

    Animalshepatocyte SIRT6 manipulation in Ldlr-/- mice on Western dietliver16 weeks

    Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis

    Cells

  3. SIRT6 decreases atherosclerosis in mice.

    “SM22α-hSIRT6/ApoE-/- mice had reduced atherosclerosis, markers of senescence and inflammation compared with littermate controls”

    Animalssmooth muscle cell-specific human SIRT6 overexpression in ApoE-/- mice versus littermate controls

    SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis

    Circulation research

  4. SIRT6 protects against atherosclerosis.

    “SIRT1 and SIRT6 are the best characterized for their protective roles against inflammation, vascular aging, heart disease, and atherosclerotic plaque development.”

    Review

    SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection

    Antioxidants & redox signaling

More on SIRT6

LMNA

upin mice2no changein mice1

3 studies
  1. LMNA showed no clear effect on atherosclerosis in mice (atheroprone Apoe-/- mice with EC-specific progerin expression).

    “did not develop vascular alterations or aggravated atherosclerosis.”

    Animalsatheroprone Apoe-/- mice with EC-specific progerin expressionblood vessel

    Endothelial cell-specific progerin expression does not cause cardiovascular alterations and premature death

    Aging cell

  2. LMNA increases atherosclerosis in mice (G609G/G609G mutation on Ldlr-/- background).

    “Ldlr-/-LmnaG609G/G609G mouse aortas showed a higher atherosclerosis burden”

    AnimalsG609G/G609G mutation on Ldlr-/- backgroundaorta

    Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with Ldlr Deficiency

    Cells

  3. LMNA increases atherosclerosis in Apoe-/- mice.

    “restricting progerin expression to VSMCs is sufficient to accelerate atherosclerosis, trigger plaque vulnerability, and reduce lifespan.”

    Animalsin Apoe-/- micemales

    Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome

    Circulation

More on LMNA

Sirtuin signaling

downin humans1downin reviews1

2 studies
  1. Sirtuin signaling protects against atherosclerosis in humans.

    “nuclear, cytoplasmic, and mitochondrial sirtuins synergistically protect against cardiovascular remodeling, atherosclerosis (AS), and heart failure (HF).”

    Review

    Subcellular sirtuin signaling networks: pivotal regulators of cardiovascular homeostasis and remodeling

    Journal of molecular histology

  2. Sirtuin signaling protects against atherosclerosis (via effects on cellular senescence).

    “potential beneficial functions of sirtuins in atherosclerosis by affecting cellular senescence”

    Reviewvia effects on cellular senescence

    Combating cellular senescence by sirtuins: Implications for atherosclerosis

    Biochimica et biophysica acta. Molecular basis of disease

More on Sirtuin signaling

Clonal hematopoiesis of indeterminate potential

upin mice1upin reviews1

2 studies
  1. Clonal hematopoiesis of indeterminate potential increases atherosclerosis.

    “thereby promoting endothelial dysfunction, atherogenesis, and adverse cardiac remodeling”

    Review

    Clonal hematopoiesis and atherosclerotic cardiovascular disease: Clinical implications, biological mechanisms, and emerging therapeutic strategies

    Journal of the Formosan Medical Association = Taiwan yi zhi

  2. Clonal hematopoiesis of indeterminate potential increases atherosclerosis in mice (clonal hematopoiesis in murine models).

    “Murine models provide compelling evidence that a major mechanism of increased cardiovascular mortality in the context of clonal hematopoiesis is accelerated atherogenesis driven by inflammasome-mediated endothelial injury”

    Reviewclonal hematopoiesis in murine models

    Clinical consequences of clonal hematopoiesis of indeterminate potential

    Blood advances

More on Clonal hematopoiesis of indeterminate potential

Age

upin humans1upin pigs1

2 studies
  1. Age is linked with higher atherosclerosis in humans (steeper midlife rise in women).

    “prevalence increased with age, with a later, steeper midlife rise among women”

    Humanssteeper midlife rise in women

    Prevalence of Silent Atherosclerosis across Adult Life

    The New England journal of medicine

  2. Age increases atherosclerosis in pigs (lean) (35% vs 1%).

    “LAD plaque burden: young lean (1%), old lean (35%), and young MetS (37%).”

    Animalsleanleft anterior descending artery

    Age and Metabolic Syndrome-dependent acceleration of coronary artery disease in miniature Ossabaw swine

    Physiology

NFE2L2

downin reviews1upin reviews1

2 studies
  1. NFE2L2 decreases atherosclerosis.

    “to preserve cellular homeostasis and function and delay the progression of atherosclerosis.”

    Review

    Nrf2 Connects Cellular Autophagy and Vascular Senescence in Atherosclerosis: A Mini-Review

    Journal of lipid and atherosclerosis

  2. NFE2L2 increases atherosclerosis (shown by total lack (knockout) of Nrf2 being protective).

    “on the other hand, total lack of Nrf2 is protective against atherosclerosis development.”

    Reviewshown by total lack (knockout) of Nrf2 being protective

    Nrf2 in aging - Focus on the cardiovascular system

    Vascular pharmacology

More on NFE2L2

GPNMB

downin mice1upin mice1

2 studies
  1. GPNMB protects against atherosclerosis in mice (shown by depletion).

    “Depletion of Gpnmb led to impairment of vascular function and enhanced atherogenesis in mice”

    Animalsshown by depletion

    Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells

    Scientific reports

  2. GPNMB increases atherosclerosis in mice.

    “reduced atherosclerotic burden in apolipoprotein E knockout mice on a high-fat diet”

    Animalsshown by ablation of Gpnmb-positive cells in apolipoprotein E knockout mice on high-fat diet

    Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice

    Nature aging

More on GPNMB

Autophagy

downin mice2

2 studies
  1. Autophagy protects against atherosclerosis in mice (shown by genetic disruption in smooth muscle cells of young mice on hyperlipidemia).

    “Genetic disruption of autophagy in smooth muscle cells of young mice exposed to hyperlipidemia led to increased aortic Parkin and IL-6 levels, impaired mitochondrial function, and enhanced atherogenesis.”

    Animalsshown by genetic disruption in smooth muscle cells of young mice on hyperlipidemiasmooth muscle cells

    Age-Associated Mitochondrial Dysfunction Accelerates Atherogenesis

    Circulation research

  2. Autophagy protects against atherosclerosis in endothelial autophagy-deficient mice.

    “Specific deficiency in endothelial autophagy in a murine model of atherosclerosis stimulates the development of atherosclerotic lesions”

    Reviewin endothelial autophagy-deficient micevasculature

    Endothelial autophagic flux hampers atherosclerotic lesion development

    Autophagy

More on Autophagy

All 86

Associations

206

Cellular senescence

upin reviews10upin humans5upin human cells1

16 studies
  1. Cellular senescence is associated with atherosclerosis in humans.

    “an upregulation of both CTSL and NICD, along with elevated cellular senescence in the plaques isolated from patients with atherosclerosis, was observed”

    Humansatherosclerotic plaque

    Ligand-Independent Activation of Notch1 by Cathepsin L Induces CUX1/p16INK4a-Dependent Endothelial Senescence Associated With Atherosclerosis

    Aging cell

  2. Cellular senescence is associated with atherosclerosis.

    “dissect the intrinsic association between macrophage senescence and CVDs, particularly atherosclerosis, myocardial infarction, and chronic heart failure.”

    Review

    The role of macrophage senescence in cardiovascular diseases

    Cellular signalling

  3. Cellular senescence is associated with atherosclerosis (senescent endothelial cells, vascular smooth muscle cells and macrophages).

    “The involvement of senescent endothelial cells, vascular smooth muscle cells, and macrophages in the initiation and progression of atherosclerosis is also discussed.”

    Reviewsenescent endothelial cells, vascular smooth muscle cells and macrophages

    The Role of Cellular Senescence and SASP in the Pathogenesis of Atherosclerosis and the Therapeutic Potential of Senolytic Strategies in Cardiovascular Diseases

    Biomedicines

  4. Cellular senescence raises the risk of atherosclerosis in atherosclerotic plaques.

    “Cell senescence is increasingly recognized as a key driver of atherosclerosis progression.”

    Reviewin atherosclerotic plaques

    Senescence as a Driver of Smooth Muscle Cell Plasticity and Atherosclerosis: Mechanisms and Therapeutic Opportunities

    Cells

  5. Cellular senescence is associated with atherosclerosis in humans (aging).

    “Clinically, vascular senescence is linked with hypertension, atherosclerosis, and increased overall cardiovascular risk.”

    Reviewaging

    Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects

    Biogerontology

  6. Cellular senescence raises the risk of atherosclerosis in humans.

    “senescent endothelial cells and vascular smooth muscle cells, and the potential link between vascular and myeloid cells, in impairing plaque stability and promoting the progression of atherosclerosis”

    Reviewblood vessel

    Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging

    Vascular pharmacology

  7. Cellular senescence raises the risk of atherosclerosis.

    “cellular senescence contributes to the pathogenesis of atherosclerosis.”

    Review

    Understanding the intricacies of cellular senescence in atherosclerosis: Mechanisms and therapeutic implications

    Ageing research reviews

  8. Cellular senescence raises the risk of atherosclerosis.

    “senescence of various types of cells, such as endothelial cells (ECs), vascular smooth muscle cells (VSMCs), macrophages, endothelial progenitor cells (EPCs), and adipose-derived mesenchymal stem cells (AMSCs) contributes to atherosclerosis.”

    Review

    New insight into dyslipidemia-induced cellular senescence in atherosclerosis

    Biological reviews of the Cambridge Philosophical Society

  9. Cellular senescence raises the risk of atherosclerosis.

    “effects of cellular senescence on the development of atherosclerosis through diverse physiopathological changes”

    Review

    Advances in relationship between cell senescence and atherosclerosis

    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

  10. Cellular senescence raises the risk of atherosclerosis.

    “Underlying the physiopathology of atherosclerosis are cellular senescence, oxidative stress, and inflammation.”

    Review

    Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis

    Journal of personalized medicine

All 16

More on Cellular senescence

Inflammation

upin humans7upin reviews5upin silico2

14 studies
  1. Inflammation raises the risk of atherosclerosis in humans.

    “chronic low-grade inflammation, or “inflammaging,” is increasingly recognized as an important contributor to atherosclerosis and cardiovascular events in older adults.”

    Review

    Inflammaging and Acute Coronary Syndrome in Elderly Patients: Pathophysiological Mechanisms, Therapeutic Implications and Future Perspectives

    Life (Basel, Switzerland)

  2. Inflammation is associated with atherosclerosis in silico (hallmark enrichment and network proximity analysis).

    “biologically meaningful disease-associated processes, like "Loss of proteostasis" in Alzheimer's disease and "Chronic inflammation" in atherosclerosis as highly significant hallmarks.”

    In silicohallmark enrichment and network proximity analysis

    An integrated resource for systems-level analysis of aging hallmarks and associated genes

    Biogerontology

  3. Inflammation is associated with atherosclerosis in osteoarthritis.

    “systemic inflammatory burden is closely associated with a cascade of comorbidities, including endothelial dysfunction and atherosclerosis potentially mediated by shared mechanisms”

    Reviewin osteoarthritis

    Systemic implications of osteoarthritis: from local degeneration to systemic metabolic Dysregulation

    Journal of translational medicine

  4. Inflammation raises the risk of atherosclerosis in humans (chronic inflammatory states) (77% in moderate-to-severe psoriasis; 54% vs 42% in HIV).

    “Recurrent topic-level signals support a role for chronic inflammatory states—including rheumatoid arthritis, psoriasis, systemic lupus erythematosus, and human immunodeficiency virus infection—in amplifying prevalence beyond traditional risk prediction”

    Reviewchronic inflammatory states

    Atherosclerosis Prevalence: Scoping Review with ☸SAIMSARA

    SAIMSARA Journal

  5. Inflammation raises the risk of atherosclerosis in humans.

    “CLGI supports the development and progression of metabolic disorders, atherosclerosis, metabolically driven liver disease”

    Review

    Chronic low-grade inflammation as a key mechanism in the development of civilization diseases - a narrative review

    Journal of Education Health and Sport

  6. Atherosclerosis is associated with inflammation in unstable plaques.

    “SCMO studies revealed specific inflammatory immune subsets in unstable plaques”

    Reviewin unstable plaques

    Single-cell multi-omics for precision cardiovascular and longevity medicine: from methods to clinical translation

    Frontiers in aging

  7. Inflammation raises the risk of atherosclerosis in humans (cardiovascular aging).

    “chronic inflammatory state associated with inflammaging compromises vascular integrity and function, contributing to atherosclerosis, endothelial dysfunction, arterial stiffening, and hypertension”

    Reviewcardiovascular aging

    Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications

    Frontiers in cardiovascular medicine

  8. Inflammation is associated with atherosclerosis.

    “Accumulating evidence has revealed that inflammaging in vascular and cardiac tissues is associated with the emergence of pathological states such as atherosclerosis and hypertension.”

    Review

    Inflammaging: mechanisms and role in the cardiac and vasculature

    Trends in endocrinology and metabolism: TEM

  9. Inflammation is associated with atherosclerosis.

    “Atherosclerosis is a characteristic disease of vascular ageing, which is closely related to the enhancement of vascular inflammation.”

    Review

    Mechanism of oxidized phospholipid-related inflammatory response in vascular ageing

    Ageing research reviews

  10. Inflammation raises the risk of atherosclerosis in silico.

    “suggested a causal relationship between inflamm-aging and atherosclerosis.”

    In silico

    The Inflamm-Aging Model Identifies Key Risk Factors in Atherosclerosis

    Frontiers in genetics

All 14

More on Inflammation

Clonal hematopoiesis of indeterminate potential

upin humans8upin reviews3upin mice1

12 studies
  1. Clonal hematopoiesis of indeterminate potential is associated with atherosclerosis in humans.

    “Particular attention is given to clonal hematopoiesis as a molecular bridge between malignant predisposition and atherosclerosis”

    Review

    Molecular basis of coronary artery disease-malignancy comorbidity: inflammation, immunometabolism, thrombosis, and cardio-oncology translation

    Frontiers in immunology

  2. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerosis in hyperlipidemic mice.

    “Complementary experimental studies in hyperlipidemic mice support a causal contribution to atherosclerosis for several CHIP drivers”

    Reviewin hyperlipidemic mice

    Hematopoietic somatic mutations in atherosclerotic cardiovascular disease

    Atherosclerosis

  3. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerosis in humans.

    “Certain subtypes of CHIP may give rise to proinflammatory immune cells, which, in turn, may promote atherosclerosis progression.”

    Review

    Clonal Hematopoiesis in Cardiovascular Risk: Focus on Inflammatory Mechanisms

    Journal of clinical medicine

  4. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerosis in humans.

    “contribute to a pro-inflammatory milieu that promotes atherosclerosis, heart failure, and other vascular complications.”

    Review

    Clonal hematopoiesis, inflammaging, and vascular disease: mechanisms, risk stratification, and therapeutic frontiers in older adults

    Acta pharmacologica Sinica

  5. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerosis in humans (self-reinforcing cycle).

    “inflammatory stress accelerates clonal expansion, creating a self-reinforcing cycle that contributes to atherosclerosis and other inflammation-associated complications.”

    Reviewself-reinforcing cycle

    The interplay of clonal hematopoiesis and cancer: Clinical implications in oncology

    Cancer treatment reviews

  6. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerosis in type 2 diabetes.

    “accelerating atherosclerosis, insulin resistance, and vascular inflammation.”

    Reviewin type 2 diabetes

    Clonal Haematopoiesis in Type 2 Diabetes: A Review of Mechanistic Links With Inflammation and Cardiovascular Disease

    Diabetes/metabolism research and reviews

  7. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerosis.

    “CHIP is well-established as a contributor to atherosclerosis and cardiovascular disease through its promotion of chronic inflammation.”

    Review

    Clonal hematopoiesis of indeterminate potential (CHIP) in cerebromicrovascular aging: implications for vascular contributions to cognitive impairment and dementia (VCID)

    GeroScience

  8. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerosis in humans.

    “Clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a previously unrecognized, potent, age-related, and common risk factor for atherosclerosis.”

    Reviewperipheral blood

    Clonal hematopoiesis and atherosclerosis

    The Journal of clinical investigation

  9. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerosis in elderly patients.

    “CHIP is commonly observed in elderly patients. It is characterized by an increase in blood cell clones with somatic mutations, resulting in an increased risk of hematological cancer and atherosclerotic CVD.”

    Reviewin elderly patients

    Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease

    International journal of molecular sciences

  10. Clonal hematopoiesis of indeterminate potential is associated with atherosclerosis in humans.

    “The third actor is clonal hematopoiesis: it constitutes a link between ageing and atherosclerosis”

    Review

    Progeria, atherosclerosis and clonal hematopoiesis: links and future perspectives

    Mechanisms of ageing and development

All 12

More on Clonal hematopoiesis of indeterminate potential

Vascular aging

upin humans2mixedin reviews1upin reviews1

4 studies
  1. vascular aging is associated with atherosclerosis (as a transversal dimension across all phases of the framework).

    “a biological process that modulates every phase of the cascade”

    Reviewas a transversal dimension across all phases of the framework

    A Chronological Framework for Atherosclerosis: From Environmental Pressure to Clinical Disease, with Vascular Aging as a Transversal Dimension

    Preprints.orgPreprint

  2. vascular aging raises the risk of atherosclerosis in humans.

    “is a common pathogenesis leading to the development of atherosclerosis, Alzheimer's disease, and other conditions among older adults.”

    Review

    The Role and Mechanism of Vascular Aging in Geriatric Vascular Diseases

    Aging and disease

  3. Vascular aging raises the risk of atherosclerosis in humans.

    “Vascular aging (VA) is recognized as a pivotal factor in the development and progression of atherosclerosis (AS).”

    Review

    Vascular Aging and Atherosclerosis: A Perspective on Aging

    Aging and disease

  4. Vascular aging raises the risk of atherosclerosis.

    “Vascular aging is unmodifiable risk factor for diseases like diabetes, hypertension, atherosclerosis, and hyperlipidemia.”

    Review

    Targeting Epigenetic Mechanisms in Vascular Aging

    Frontiers in cardiovascular medicine

Physical activity

downin humans2upin humans1

3 studies
  1. Physical activity is associated with atherosclerosis in humans (Low physical activity in non-smoking Pakistani adults).

    “Family history of cardiovascular diseases (p < 0.001), high stress level (p = 0.001) and low physical activity (p = 0.002) showed significant association with atherosclerosis.”

    HumansLow physical activity in non-smoking Pakistani adults

    Lack of Association between the Prothrombin gene rs1799963 G/A polymorphism and atherosclerosis risk in non-smokers from Sargodha, Pakistan

    Research SquarePreprint

  2. Physical activity is linked with a lower risk of atherosclerosis in humans (multivariable MR).

    “PA during 2 AM to 4 AM and 10 AM to 12 PM had directly protective effect of total AS”

    Humansmultivariable MR

    Unlocking the Clock: Optimal Physical Activity Timing for Cardiovascular Disease Prevention

    Journal of physical activity & health

  3. Physical activity lowers the risk of atherosclerosis in humans.

    “higher cardiorespiratory fitness and physical activity were associated with lower burden”

    Review

    Atherosclerosis Prevalence: Scoping Review with ☸SAIMSARA

    SAIMSARA Journal

More on Physical activity

Lipoprotein

upin humans2upin reviews1

3 studies
  1. Lipoprotein raises the risk of atherosclerosis.

    “Lp(a) is more atherogenic than low-density lipoprotein (LDL) on a per-particle basis”

    Review

    The Roles of Lipoprotein(a) in Atherosclerosis - Minding the Knowledge Gaps

    Current atherosclerosis reports

  2. Lipoprotein raises the risk of atherosclerosis in humans (elevated Lp(a)).

    “Elevated plasma concentrations of lipoprotein(a) [Lp(a)] are a causal and independent risk factor for atherosclerotic cardiovascular disease”

    Reviewelevated Lp(a)

    Lipoprotein(a): a unique lipoprotein at the crossroads of atherosclerosis and thrombosis

    Current opinion in lipidology

  3. Lipoprotein is associated with atherosclerosis in humans (female premature coronary artery disease).

    “Elevated triglyceride-rich lipoproteins and lipoprotein(a) are highly associated with early atherosclerosis.”

    Reviewfemale premature coronary artery diseasefemales

    Premature coronary artery disease in women: sex-specific risk factors, pathogenetic mechanisms and clinical implications

    Annals of medicine

More on Lipoprotein

Dementia

upin humans3HR 1.39

3 studies
  1. Atherosclerosis is linked with a higher risk of dementia in humans (plaque without stenosis vs without carotid atherosclerosis) (HR: 1.39 [95%CI: 1.05-1.83]).

    “risk of dementia was increased in the presence of plaque without stenosis (HR: 1.39 [95%CI: 1.05-1.83])”

    Humansplaque without stenosis vs without carotid atherosclerosiscarotid artery9.7 yearsn = 4,267

    Asymptomatic carotid artery stenosis, cognitive decline and dementia: a prospective population-based cohort study

    medRxivPreprint

  2. Atherosclerosis is linked with a higher risk of dementia in patients with stroke.

    “Atherosclerosis was associated with an increased risk of post-stroke dementia.”

    Humansin patients with stroke

    Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: A systematic review and meta-analysis

    Ageing research reviews

  3. Atherosclerosis is associated with dementia in humans.

    “Prominent risk factors for acute myocardial infarction including hypertension and atherosclerosis have been independently associated with an increased risk for cognitive decline and all-cause dementia and Alzheimer disease”

    Review

    Connections Between Hypertension, Atherosclerosis, Acute Myocardial Infarction, and Risk of Dementia

    Cardiology in review

More on Dementia

Age

upin humans2upin reviews1

3 studies
  1. Age is linked with a higher risk of atherosclerosis in humans (representative Danish sample) (0.3% to 17.3%).

    “The prevalence of any atherosclerotic disease increased from 0.3% in the youngest age-strata (18–29 years) to 17.3% in the oldest age-strata (60–70 years)”

    Humansrepresentative Danish samplen = 160,000

    The Prevalence of Clinical Atherosclerosis in Denmark

    AHA Scientific Sessions 2025 abstract

  2. Age raises the risk of atherosclerosis in humans (>50% in middle-aged cohorts, ~63% in ages 40-54, >80% in elderly).

    “The mapped evidence indicates that subclinical atherosclerosis is a pervasive signal across the lifespan, with imaging-detected plaque exceeding 50% in many middle-aged cohorts”

    Review

    Atherosclerosis Prevalence: Scoping Review with ☸SAIMSARA

    SAIMSARA Journal

  3. Age raises the risk of atherosclerosis.

    “Aging is a major independent risk factor for atherosclerosis (AS)”

    Review

    The Complex Bidirectional Relationship Between Aging and Atherosclerosis: Mechanistic Insights and Translational Opportunities

    Aging and disease

Cardiovascular disease

upin reviews2upin humans1HR 1.85

3 studies
  1. Atherosclerosis is linked with a higher risk of cardiovascular disease in humans (controlling for covariates) (HR = 1.85, 95%CI = 1.02-3.37, p = 0.0420).

    “CVD risk and all-cause mortality were higher in participants with atherosclerosis, while controlling for covariates (CVD HR = 1.85, 95%CI = 1.02-3.37, p = 0.0420”

    Humanscontrolling for covariatesmedian follow-up of 17.8 yearsn = 1,376

    Subclinical atherosclerosis in adolescents and young adults and the risk of cardiovascular disease: The Strong Heart Family Study (SHFS)

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  2. Atherosclerosis raises the risk of cardiovascular disease.

    “Atherosclerosis is a chronic, progressive disease of the arterial wall and the principal pathological substrate underlying most cardiovascular diseases”

    Review

    Atherosclerosis: A Pathologist's Perspective

    Journal of cardiovascular development and disease

  3. Atherosclerosis raises the risk of cardiovascular disease.

    “Atherosclerosis is an inflammatory disease of the large arteries that is the major cause of cardiovascular disease (CVD) and stroke.”

    Review

    Atherosclerosis: Recent developments

    Cell

More on Cardiovascular disease

Sarcopenia

upin humans2upin reviews1

3 studies
  1. Sarcopenia is associated with atherosclerosis in elderly patients (75.0% vs 46.3% (p=0.01)).

    “incidence of carotid arteries atherosclerotic lesions in patients without sarcopenia was 50 (46.3%), in patients with sarcopenia - 18 (75.0%) (p=0.01).”

    Humansin elderly patients

    Stroke risk stratification in elderly patients with comorbid sarcopenia and atherosclerosis

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

  2. Sarcopenia raises the risk of atherosclerosis in aging.

    “skeletal muscle dysfunction exacerbates systemic insulin resistance and inflammatory cascades that accelerate endothelial damage and atherogenesis”

    Reviewin aging

    Unraveling the metabolic pathways between atherosclerosis and sarcopenia

    Frontiers in endocrinology

  3. Sarcopenia is associated with atherosclerosis in humans.

    “shared immune-mediated pathways”

    Review

    Immune-mediated interactions between sarcopenia and atherosclerosis in aging

    Immunity & ageing : I & A

More on Sarcopenia

All 206

Trial sponsors

Funding

196 grants since 2016

National Heart, Lung, and Blood Institute$147MNational Institute on Aging$80.4MJapan Society for the Promotion of Science¥182M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies link atherosclerosis with older age, increasing frailty in people with type 2 diabetes, and sarcopenia in elderly patients; a preprint links carotid plaque without stenosis with higher dementia risk. Mouse studies report decreases with exercise, but caloric restriction decreases atherosclerosis in obese hypercholesterolemic mice and increases it in ApoE-deficient mice fed chow or HCHF diets.

  2. Summary rewritten as its findings changed.

    As it read before

    Atherosclerosis is associated with chronological age in a human brain study and with increasing frailty in people with type 2 diabetes. Mouse studies report reductions with quercetin, fisetin, and SIRT6, while caloric restriction decreases atherosclerosis in obese hypercholesterolemic mice but increases it in ApoE-deficient mice.

  3. Summary rewritten as its findings changed.

    As it read before

    Human studies link atherosclerosis to older age and, in type 2 diabetes, increasing frailty; a human preprint associates carotid plaque without stenosis with dementia risk. Mouse studies report reduced atherosclerosis with exercise and quercetin, but caloric restriction decreases it in obese hypercholesterolemic mice and increases it in ApoE-deficient mice.

  4. Summary rewritten as its findings changed.

    As it read before

    Human studies associate atherosclerosis with age and frailty; a preprint links carotid plaque without stenosis to subsequent dementia. In mice, exercise reduces aortic atherosclerosis and verteporfin reduces it in progeroid animals, whereas six-month caloric restriction increases it in ApoE-deficient mice fed chow or HCHF diets.

  5. Summary rewritten as its findings changed.

    As it read before

    A human cohort links ultra-processed food intake to increased atherosclerosis risk, while mouse studies show accelerated disease with caloric restriction or 4-vinylcyclohexene diepoxide exposure. Reviews highlight dyslipidemia, inflammation, disrupted circadian blood pressure rhythms, and specific genetic variants as human risk factors.

Latest

bioRxiv

Loss of nuclear support proteins harms mouse hearts and arteries

Median survival was 14.6% lower in artery-disease-prone mice lacking the proteins in blood-vessel-lining cells than in comparison mice.Median survival was 14.6% lower in artery-disease-prone mice lacking the proteins in blood-vessel-lining cells than in comparison mice.

Preprint: mouse studyMechanisms
Aging Cell

Fat-derived protein worsened signs of vessel aging in mice

In experiments with 24 young male mice over 12 weeks, an antibody against asprosin reduced signs of chemically induced blood vessel aging.In experiments with 24 young male mice over 12 weeks, an antibody against asprosin reduced signs of chemically induced blood vessel aging.

Experiments in miceMechanisms
medRxiv

Rare gene variants linked to heart and blood vessel diseases

An analysis of up to 483,311 UK Biobank participants found 86 gene–disease associations, including 46 new links and 40 established ones.An analysis of up to 483,311 UK Biobank participants found 86 gene–disease associations, including 46 new links and 40 established ones.

Preprint: genetic association · 483,311 peopleMechanisms

See all 4,674 papers on atherosclerosis